GlaxoSmithKline | GSK - Stammkapital

Aktienkurs
2,156.50
Täglich Wechseln
31.50 1.48%
Monatlich
4.48%
Jährlich
69.14%
Q2 Prognose
2,097.48




Stammkapital Veränderung Datum
AbbVie USD 1.77B 1.75B 2025-06
Alcon AG USD 487.4M 7.2M 2025-12
Almirall EUR 214.79M 0 2025-12
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Bayer EUR 982.42M 0 2025-12
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Eli Lilly USD 946.83M 354.23M 2025-06
Fresenius EUR 563.24M 0 2025-09
Fresenius Medical Care EUR 279.29M 10.56M 2025-12
Galapagos EUR 65.9M 0 2025-12
Genmab DKK 61.62M 52K 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Glaxosmithkline GBP 4.08B 49.43M 2025-12
GRIFOLS EUR 680.58M 846K 2025-12
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Lonza CHF 68.64M 0 2025-12
Merck EUR 434.78M 0 2025-12
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.91B 10.64M 2025-12
Novo Nordisk DKK 4.44B 0 2025-12
Orion EUR 140.69M 0 2025-09
Pfizer USD 5.69B 1000K 2025-09
Philips EUR 951.29M 310K 2025-12
Recordati EUR 205.83M 270K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Smith & Nephew USD 875.96M 1.61M 2025-12
UCB EUR 190.36M 365.15K 2025-12